Warner-Lambert's Rezulin Might Help Cure Cancer, Study Says
[same news as that in the Reuters article at reply # 661]
Bloomberg News
March 30, 1999, 2:02 p.m. ET
Morris Plains, New Jersey, March 30 (Bloomberg) -- Warner-
Lambert Co.'s diabetes drug Rezulin could help cure a rare cancer
called liposarcoma and also protect patients with prostate,
breast, colon and lung cancers, United Press International said,
citing a study by researchers at Boston's Dana-Farber Cancer
Institute. Rezulin binds onto a receptor that controls the growth
of cancer cells, letting them die normally instead of dividing
uncontrollably, the study said. Harvard Medical School Professor
George Demetri said the drug could treat more than 500,000 people
diagnosed with cancer annually, and the study said more than
90 percent of liposarcoma cells revert to normal in the presence
of the drug, UPI reported.
Rezulin has benefits that outweigh its risks when used in
combination with other diabetes drugs, a panel of diabetes
experts advising the U.S. Food and Drug Administration said last
week.
(UPI 3/30 NH UPI )
|
